Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Development of autologous humanized leukemia models for immunotherapy testing
Gordon, P. M. (PI), Macchietto, M. (CoI), Williams, R. L. (CoI), Byersdorfer, C. A. (Co-Principal Investigator), Ampudia-Mesias, E. (Other Role), Ostergaard, J. (Other Role) & Wang, X. (Other Role)
4/17/26 → 3/31/31
Project: Research project
-
EPG-HU1418-201; A Phase 2/3, Single-Arm Study with 2 Cohorts to Characterize and Evaluate the Efficacy, Safety, and Tolerability of hu14.18K322A ...
Williams, R. L. (PI)
10/10/25 → 10/9/36
Project: Research project
-
PER CASE REIMBURSEMENT: COGRF PEP-CTN
Williams, R. L. (PI), Elling, R. C. (Other Role), Fullenkamp, A. M. (Other Role) & Vang, M. (Other Role)
COG RESEARCH FOUNDATION, LLC, NIH NATIONAL CANCER INSTITUTE
8/1/25 → 7/31/29
Project: Research project
-
UMN/COG Research Fdn LLC - Master Site Agreement (UMN Ref: AGMT-1510)
Williams, R. L. (PI)
8/1/25 → 7/31/30
Project: Research project
-
WORKLOAD INTENSITY: COGRF PEP-CTN WLI (UM1CA228823)
Williams, R. L. (PI)
COG RESEARCH FOUNDATION, LLC, NIH NATIONAL CANCER INSTITUTE
8/1/25 → 7/31/29
Project: Research project
-
An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemia
Gordon, P. M., Williams, R. L., Ostergaard, J., Lee, K. C., Bui, H. N., Muretta, J. M., Wilson, B. S., Beder, T., Baldus, C. D., Lambert, L., Deonovic, B. E., Singleton, T., Tasian, S. K. & Winter, S. S., Aug 2025, In: Blood Neoplasia. 2, 3, 100120.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Genetic Determinants of Cancer Susceptibility
Williams, R. L. & Williams, K. B., Jan 1 2025, Comprehensive Toxicology. Elsevier, p. Vol13:578-Vol15:613Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease
Ma, L., Koehn, B., Zaiken, M., Hippen, K. L., Smith, K., Allred, J., Williams, R., Yao, K., Fink, J., Saha, A., Koop, B., Payne, N., Widelak, R., Panoskaltsis-Mortari, A., Riddle, M. J., Tolar, J., Eide, C., Xia, L., Witty, A. D. & Mehta, A. K. & 9 others, , Oct 23 2025, In: Blood. 146, 17, p. 2047-2062 16 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Long-term survival after luveltamab tazevibulin, a novel folate receptor-α (FRα) targeting antibody drug conjugate (ADC) in children with CBFA2T3::GLIS2 acute myeloid leukemia (AML).
Williams, R. L., Miller, L., Massaro, S., Krieger, E., Pauly, M. G., Nelson, C., Johnson, R., Welch, J. J. G., Bhojwani, D., Moghimi, B., Neff, P., Horton, T., Imran, H., Ribeiro, R. C., Guinipero, T., Bautista, F., Kutny, M., Johnson, A. J., Lewing, K. & Meshinchi, S., Jun 2025, In: Journal of Clinical Oncology. 43, p. e22007-e22007Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
Greengard, E., Williams, R., Moriarity, B., Liu, X., Minard, C. G., Reid, J. M., Fisher, T., Evans, E., Pastore, D. R., Zauderer, M., Voss, S., Fox, E. & Weigel, B. J., Jun 2024, In: Pediatric Blood and Cancer. 71, 6, e30938.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations